drugset / Trial / NCT00567385

Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

NCT00567385

Phase 4 Completed 176 enrolled Novo Nordisk A/S
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to evaluate the acceptance of the new liquid growth hormone formulation, somatropin, in children with growth hormone deficiency.

Timeline

Start
2003-03-10
Primary completion
2004-03-22
Completion
2004-03-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic